國家衛生研究院 NHRI:Item 3990099045/8209
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 856766      Online Users : 885
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8209


    Title: Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression
    Authors: Chen, JY;Li, CF;Kuo, CC;Tsai, K;Hou, MF;Hung, WC
    Contributors: National Institute of Cancer Research;Institute of Cellular and Systems Medicine
    Abstract: IntroductionExpression of indoleamine 2, 3-dioxygenase (IDO) in primary breast cancer increases tumor growth and metastasis. However, clinical significance of stromal IDO and the regulation of stromal IDO are unclear.MethodsMetabolomics and enzyme-linked immunosorbent assay (ELISA) were used to study the effect of cyclooxygenase-2 (COX-2)-overexpressing breast cancer cells on IDO expression in co-cultured human breast fibroblasts. Biochemical inhibitors and short hairpin RNA (shRNA) were used to clarify how prostaglandin E2 (PGE2) up-regulates IDO expression. Associations of stromal IDO with clinicopathological parameters were tested in tumor specimens. Orthotopic animal model was used to examine the effect of COX-2 and IDO inhibitors on tumor growth.ResultsKynurenine, the metabolite generated by IDO, increases in the supernatant of fibroblasts co-cultured with COX-2-overexpressing breast cancer cells. PGE2 released by cancer cells up-regulates IDO expression in fibroblasts through an EP4/ Signal transducer and activator of transcription 3 (STAT3)-dependent pathway. On the other hand, fibroblast-secreted kynurenine promotes the formation of the E-cadherin/Aryl hydrocarbon receptor (AhR)/S-phase kinase-associated protein 2 (Skp2) complex, resulting in degradation of E-cadherin to increase breast cancer invasiveness. The enhancement of motility of breast cancer cells induced by co-culture with fibroblasts is suppressed by the IDO inhibitor 1-methyl-tryptophan. Pathological analysis demonstrates that up-regulation of stromal IDO is a poor prognosis factor and is associated with of COX-2 overexpression. Co-expression of cancer COX-2 and stromal IDO predicts a worse disease-free and metastasis-free survival. Finally, COX-2 and IDO inhibitors inhibit tumor growth in vivo.ConclusionIntegration of metabolomics, molecular and pathological approaches reveals the interplay between cancer and stroma via COX-2 and IDO promotes tumor progression and predicts poor patient survival.
    Date: 2014-07
    Relation: Breast Cancer Research. 2014 Jul;16(4):Article number 410.
    Link to: http://dx.doi.org/10.1186/s13058-014-0410-1
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1465-542X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000344310300018
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84906834688
    Appears in Collections:[Kelvin Kun-Chih Tsai] Periodical Articles
    [Wen-Chun Hung] Periodical Articles
    [Cheng-Chin Kuo] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    BMC2014072901.pdf764KbAdobe PDF629View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback